These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 29362402)

  • 21. Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development.
    Feng J; Byrne NM; Al Jamal W; Coulter JA
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxic Signalling in Tumour Stroma.
    Laitala A; Erler JT
    Front Oncol; 2018; 8():189. PubMed ID: 29896451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia inducible factor-1 alpha and multiple myeloma.
    Bhaskar A; Tiwary BN
    Int J Adv Res (Indore); 2016 Jan; 4(1):706-715. PubMed ID: 26900575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia inducible factors in cancer stem cells.
    Heddleston JM; Li Z; Lathia JD; Bao S; Hjelmeland AB; Rich JN
    Br J Cancer; 2010 Mar; 102(5):789-95. PubMed ID: 20104230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
    Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
    Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
    Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
    Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells.
    Harrison H; Pegg HJ; Thompson J; Bates C; Shore P
    BMC Cancer; 2018 Jun; 18(1):674. PubMed ID: 29925335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging and Targeting of the Hypoxia-inducible Factor 1-active Microenvironment.
    Kizaka-Kondoh S; Tanaka S; Hiraoka M
    J Toxicol Pathol; 2009 Jun; 22(2):93-100. PubMed ID: 22271982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha.
    Lin Q; Cong X; Yun Z
    Mol Cancer Res; 2011 Jun; 9(6):757-65. PubMed ID: 21571835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models.
    Phelan JP; Reen FJ; Dunphy N; O'Connor R; O'Gara F
    BMC Cancer; 2016 Jul; 16():476. PubMed ID: 27416726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1α.
    Miao ZF; Wang ZN; Zhao TT; Xu YY; Gao J; Miao F; Xu HM
    Stem Cells; 2014 Dec; 32(12):3062-74. PubMed ID: 25142304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
    Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
    Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner.
    Ren J; Guo H; Wu H; Tian T; Dong D; Zhang Y; Sui Y; Zhang Y; Zhao D; Wang S; Li Z; Zhang X; Liu R; Qian J; Wei H; Jiang W; Liu Y; Li Y
    Oncol Rep; 2015 Apr; 33(4):1929-37. PubMed ID: 25647524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAFs and TAMs: maestros of the tumour microenvironment.
    Komohara Y; Takeya M
    J Pathol; 2017 Feb; 241(3):313-315. PubMed ID: 27753093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia Enhances Immunosuppression by Inhibiting CD4+ Effector T Cell Function and Promoting Treg Activity.
    Westendorf AM; Skibbe K; Adamczyk A; Buer J; Geffers R; Hansen W; Pastille E; Jendrossek V
    Cell Physiol Biochem; 2017; 41(4):1271-1284. PubMed ID: 28278498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
    Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
    Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
    Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma.
    McShane R; Arya S; Stewart AJ; Caie PD; Bates M
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188598. PubMed ID: 34332022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.